Quantcast

Latest Neuroimmunology Stories

2014-06-17 16:26:18

The Conrad N. Hilton Foundation is issuing an open invitation for research into Multiple Sclerosis, the leading cause of neurological disability in young adults. LOS ANGELES, June 17, 2014 /PRNewswire-USNewswire/ -- The Conrad N. Hilton Foundation is issuing an open invitation to submit proposals for the Marilyn Hilton Award for Innovation in Multiple Sclerosis Research. The goal of the award is to stimulate innovative and potentially paradigm-shifting research on Progressive...

2014-03-18 12:33:00

New position focuses on StemGenex' commitment to safety and efficacy while developing new technology. LA JOLLA, Calif., March 18, 2014 /PRNewswire/ -- StemGenex®, a leader in adult adipose-derived stem cell therapy, is pleased to announce that Jeremiah McDole, Ph.D. has been named Director of Clinical Research and Development. http://photos.prnewswire.com/prnvar/20140318/LA85529 "We couldn't be more excited to welcome Jeremiah," said Rita Alexander, President of StemGenex....

2013-12-18 23:03:17

US Reps. Israel and Fattah sign agreement to pursue accelerated Alzheimer’s research. Manhasset, NY (PRWEB) December 18, 2013 The Feinstein Institute for Medical Research Monday hosted the signing of a Memorandum of Understanding (MOU) dedicated to creating a partnership in neuroscience research, and in particular, research on Alzheimer’s disease. US Reps. Steve Israel (D-NY), and Chakah Fattah (D-PA), along with Feinstein Institute Investigator Peter Davies, PhD, and representatives...

2013-11-21 23:20:17

Reportbuyer.com just published a new market research report: Multiple Sclerosis: KOL Insight. London (PRWEB) November 21, 2013 The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen’s Tecfidera (dimethyl fumarate) has revolutionised multiple sclerosis treatment in the US, eroding significant market share from older therapies. However, patent concerns has stalled Tecfidera’s launch in Europe. Genzyme have taken advantage of this delay with...

2011-07-18 15:08:00

GRAND RAPIDS, Mich., July 18, 2011 /PRNewswire/ -- In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers. "The implications of this study are significant," said Henry...

2011-04-25 12:03:16

Researchers uncover role of GM-CSF, an inflammatory cytokine, in T helper cells; blocking it could treat multiple sclerosis Reporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step in developing new treatments to eradicate these diseases. Researchers led by Abdolmohamad Rostami, M.D., Ph.D., Professor and Chairman of the...

2011-01-31 14:31:32

New research published in the Journal of Leukocyte Biology suggests that histamine plays an important role as an immune modulator, which could be a significant finding for multiple sclerosis research If you think histamines are your nemesis during allergy season, here's something that might change your perspective. New research published in the Journal of Leukocyte Biology (http://www.jleukbio.org) shows that histamine could be an important molecule to developing new treatments for multiple...

2010-10-28 14:34:00

Between Oct. 26-30 takes place in Sitges (Barcelona, Spain) the 10th International Congress of Neuroimmunology of the International Society of Neuroimmunology The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine. Between October 26th and 30th takes place in Sitges (Barcelona, Spain) the X International Congress of Neuroimmunology of the International Society of Neuroimmunology. This event highlights the advances...

2010-10-22 13:44:05

Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) "“ a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis. The research, led by Barrow's Fu-Dong Shi, MD, PhD, was published in the August 2010 issue of The Journal of Experimental Medicine, and simultaneously highlighted in Nature. Dr. Shi directs the Neuroimmunology...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related